John Klein serves as the chairman of Cambridge Therapeutics, which he founded. He oversees the company’s activity in combination drug therapies, drug delivery systems, and physician prescription dispensation development.
at Cambridge Therapeutic Technologies
January 2011 - at Present
John Klein has served in executive capacities for several pharmaceutical and physician service-related companies, beginning in 1988 when he became the president and CEO of Zenith Laboratories. Successful in growing revenue to $250 million and securing a purchase price of $600 million, John Klein received Business Week’s Turnaround of the Year Award for his success.
Chairman & CEO
at Dava Pharmaceutical Company
January 2005 - at Present